VBI Vaccines Inc/BC
VBIVDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000764195
VBI Vaccines Inc/BC was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jul 31, 2023; 41 institutions reported holding it in 13F filings for Q2 2024, worth $1.79M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in VBI Vaccines Inc/BC as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- −19 vs. Q4 2022
- Shares held
- 91.9M
- −2.07M (−2.2%) vs. Q4 2022
- Total value
- $27.9M
- −$8.79M (−24.0%) vs. Q4 2022
- New holders
- 2
- 20 more added
- Sold out
- 21
- 34 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VBIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 2 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 41 | $1.79M |
| Q1 2024 | 36 | $1.61M |
| Q4 2023 | 39 | $1.71M |
| Q3 2023 | 37 | $1.90M |
| Q2 2023 | 46 | $7.06M |
| Q1 2023 | 96 | $27.9M |
| Q4 2022 | 115 | $36.7M |
| Q3 2022 | 128 | $69.9M |
| Q2 2022 | 131 | $83.3M |
| Q1 2022 | 131 | $191.2M |
| Q4 2021 | 134 | $260.0M |
| Q3 2021 | 126 | $347.3M |
| Q2 2021 | 134 | $384.3M |
| Q1 2021 | 137 | $376.1M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding VBI Vaccines Inc/BC; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −88,195−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −64,737−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −45,163−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −34,899−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −21,938−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,899−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −12,626−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −12,610−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −11,001−100.0% | Sold out |
| Investors Asset Management of Georgia Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,474−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,299−100.0% | Sold out |
| 1832 Asset Management L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | 0 | Sold out |